Life sciences industry overview
The life sciences industry has played a pivotal role in tackling the impact of the COVID-19 crisis by developing the fastest novel vaccine in history. As a result, healthcare systems, governments, regulators, payers and providers, and nonprofit organizations are now looking for collaborative opportunities with life sciences companies. But within the life sciences industry, companies are challenged by the competitive pressures and constant fluctuations in market dynamics.
At Infiniti Research, we understand the current challenges facing the life sciences industry and provide customized solutions to monitor and quantify the global impact of the crisis, analyze the reimbursement environment, enhance market access and tendering strategies, track disease trends and therapeutic breakthroughs, and more. With market intelligence capabilities that span the entire spectrum of the life sciences industry, we help companies track shifts in customer preferences and make informed decisions that will help them achieve sustainability, improve operational efficiency, and increase profit margins. Our team comprises cross-functional domain experts and industry specialists who offer personalized life sciences market intelligence solutions to help our clients tackle challenges across all stages of drug development, including R&D, drug discovery, clinical trial progression, product commercialization, brand research, sales and marketing, generics and biosimilars, and managed care.
Want to learn more about how our global team of market research experts can help create new opportunities for your business? Let us know what you’re interested in, and we’ll put you on the right path.
Focus areas
Biotechnology
Recent technological advances and a rise in the prevalence of diseases have set the ball rolling for the life sciences and biotechnology industry, providing a renewed platform to revive growth.
Biochemistry
By adopting a unique combination of primary and secondary research and expert panel reviews, we help clients identify trends, opportunities and challenges impacting growth.
Microbiology
The rising demand for microbial applications in vaccine development is prompting businesses to devise futuristic strategies with life sciences market intelligence solutions.
We empower life sciences companies with balanced perspectives and expert insights on trends reshaping the business landscape.
Contact us to learn how we can help you.
Latest insights
Agribusiness Companies are Adapting to Market Shifts. Here’s Why
With decades of experience in providing insight and strategy support, we have helped several companies operating in the agribusiness industry achieve successful results.
A New Era of Refinancing in the Chemical Industry
The extraordinary restructuring and debt buildup that had taken place in the Chemical industry from 2006 to 2008 has resulted in the industry going through a phase of refinancing, which is expected to drive consolidation over the next few years....
Building an Optimal Pricing Strategy for a Flagship SaaS Product | Pricing Research
Given the importance of pricing in driving product value, it could be said that pricing research is a vital component of a company’s pricing strategy. A clear understanding and management of consumers’ reference prices will help strengthen your overall pricing strategy.
Achieving a Go To Market Advantage in Developing Markets
Businesses without a global footprint are more likely to suffer when the local economy takes a hit. A significant benefit of expanding into emerging markets is that your company will be insulated from market fluctuations due to a well-established, global presence.
Keys to Creating a Winning eCommerce Strategy
As new establishments chip away the dominance of market leaders, multinational establishments are facing a decline in sales outside their home markets. Keeping abreast of market needs at a regional or country-level will empower you to analyze and...
Understanding Structural and Strategic Barriers to Entry in Global Markets
An existing market player might deliberately lower prices or take over a potential rival by purchasing sufficient shares to gain an edge in the market. As with other methods that further reinforce the barriers, regulators may prevent this to reduce competition.